These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 7693850

  • 1. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ.
    J Exp Med; 1993 Nov 01; 178(5):1567-75. PubMed ID: 7693850
    [Abstract] [Full Text] [Related]

  • 2. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ, Noelle RJ, Roy M, Shepherd DM, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E.
    J Exp Med; 1993 Nov 01; 178(5):1555-65. PubMed ID: 7693849
    [Abstract] [Full Text] [Related]

  • 3. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R.
    Thyroid; 1996 Aug 01; 6(4):267-73. PubMed ID: 8875745
    [Abstract] [Full Text] [Related]

  • 4. An essential role for gp39, the ligand for CD40, in thymic selection.
    Foy TM, Page DM, Waldschmidt TJ, Schoneveld A, Laman JD, Masters SR, Tygrett L, Ledbetter JA, Aruffo A, Claassen E, Xu JC, Flavell RA, Oehen S, Hedrick SM, Noelle RJ.
    J Exp Med; 1995 Nov 01; 182(5):1377-88. PubMed ID: 7595208
    [Abstract] [Full Text] [Related]

  • 5. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.
    Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ.
    Science; 1993 Sep 03; 261(5126):1328-30. PubMed ID: 7689748
    [Abstract] [Full Text] [Related]

  • 6. The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.
    Marshall LS, Aruffo A, Ledbetter JA, Noelle RJ.
    J Clin Immunol; 1993 May 03; 13(3):165-74. PubMed ID: 7686564
    [No Abstract] [Full Text] [Related]

  • 7. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.
    Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ.
    J Exp Med; 1994 Jul 01; 180(1):157-63. PubMed ID: 7516405
    [Abstract] [Full Text] [Related]

  • 8. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
    Mohan C, Shi Y, Laman JD, Datta SK.
    J Immunol; 1995 Feb 01; 154(3):1470-80. PubMed ID: 7529804
    [Abstract] [Full Text] [Related]

  • 9. Diminished expression of CD40 ligand by activated neonatal T cells.
    Nonoyama S, Penix LA, Edwards CP, Lewis DB, Ito S, Aruffo A, Wilson CB, Ochs HD.
    J Clin Invest; 1995 Jan 01; 95(1):66-75. PubMed ID: 7814647
    [Abstract] [Full Text] [Related]

  • 10. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J, de Rijk D, Kasran A, Barcy S, de Groot C, de Boer M.
    Eur J Immunol; 1994 Mar 01; 24(3):508-17. PubMed ID: 7510232
    [Abstract] [Full Text] [Related]

  • 11. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M.
    Cell; 1993 Jan 29; 72(2):291-300. PubMed ID: 7678782
    [Abstract] [Full Text] [Related]

  • 12. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
    Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ.
    J Clin Invest; 1994 Sep 29; 94(3):1333-8. PubMed ID: 7521888
    [Abstract] [Full Text] [Related]

  • 13. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
    Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1099-103. PubMed ID: 7508119
    [Abstract] [Full Text] [Related]

  • 14. The expansive role of CD40 and its ligand, gp39, in immunity.
    Foy TM, Durie FH, Noelle RJ.
    Semin Immunol; 1994 Oct 01; 6(5):259-66. PubMed ID: 7532456
    [Abstract] [Full Text] [Related]

  • 15. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.
    Bajorath J, Chalupny NJ, Marken JS, Siadak AW, Skonier J, Gordon M, Hollenbaugh D, Noelle RJ, Ochs HD, Aruffo A.
    Biochemistry; 1995 Feb 14; 34(6):1833-44. PubMed ID: 7531493
    [Abstract] [Full Text] [Related]

  • 16. In vivo T-B cell interactions and cytokine-production in the spleen.
    van den Eertwegh AJ, Laman JD, Noelle RJ, Boersma WJ, Claassen E.
    Semin Immunol; 1994 Oct 14; 6(5):327-36. PubMed ID: 7532461
    [Abstract] [Full Text] [Related]

  • 17. In vivo gp39-CD40 interactions occur in the non-follicular compartments of the spleen and are essential for thymus dependent antibody responses and germinal center formation.
    van den Eertwegh AJ, Van Meurs M, Foy TM, Noelle RJ, Boersma WJ, Claassen E.
    Adv Exp Med Biol; 1994 Oct 14; 355():75-80. PubMed ID: 7535976
    [No Abstract] [Full Text] [Related]

  • 18. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM, Williams JA, Hodes RJ.
    J Immunol; 2003 Jan 15; 170(2):781-7. PubMed ID: 12517941
    [Abstract] [Full Text] [Related]

  • 19. The role of CD40 in the regulation of humoral and cell-mediated immunity.
    Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ.
    Immunol Today; 1994 Sep 15; 15(9):406-11. PubMed ID: 7524518
    [Abstract] [Full Text] [Related]

  • 20. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
    Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, Armitage RJ.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3141-7. PubMed ID: 7682232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.